Jury Says Takeda Unit Owes Bayer $155M Over Hemophilia IP
Following more than a week of trial in Delaware, a federal jury has said a Takeda Pharmaceutical Co. Ltd. unit should pay $155 million in royalties to Bayer Healthcare LLC for...To view the full article, register now.
Already a subscriber? Click here to view full article